SCHEMBL1147535

SCHEMBL1147535

CN(C)c1cccc2c(S(=O)(=O)NCCOS(C)(=O)=O)cccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.59
HDAC4 P56524 1/20 0.57
HDAC10 Q969S8 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
HDAC5 Q9UQL6 1/20 0.57
EDNRA P25101 5/20 0.54
HTR1A P08908 2/20 0.51
GBA1 P04062 2/20 0.50
GLB1 P16278 2/20 0.50
CA2 P00918 1/20 0.50
EPHX2 P34913 1/20 0.50
F2 P00734 1/20 0.50
PRSS1 P07477 1/20 0.50
PRSS2 P07478 1/20 0.50
PRSS3 P35030 1/20 0.50
CYP1A2 P05177 1/20 0.49
CYP2C19 P33261 1/20 0.49
HTT P42858 1/20 0.49
HIF1A Q16665 1/20 0.49
TDP1 Q9NUW8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15499628 0.87 HDAC4 (0.59) PTGS2HDAC4HDAC10HDAC6HDAC5
SCHEMBL18994878 0.86 PTGS2 (0.60) PTGS2HDAC4HDAC10HDAC6HDAC5
SCHEMBL15498139 0.85 EDNRA (0.57) PTGS2HDAC4HDAC10HDAC6HDAC5
SCHEMBL15743869 0.85 HDAC4 (0.57) PTGS2HDAC4HDAC10HDAC6HDAC5
SCHEMBL4126957 0.84 HDAC4 (0.71) HDAC4HDAC10HDAC6HDAC5EDNRA
SCHEMBL4139459 0.84 HDAC4 (0.75) HDAC4HDAC10HDAC6HDAC5EDNRA
SCHEMBL15499622 0.84 HDAC4 (0.56) PTGS2HDAC4HDAC10HDAC6HDAC5
SCHEMBL19922703 0.83 PTGS2 (0.53) PTGS2HDAC4HDAC10HDAC6HDAC5
SCHEMBL12686661 0.82 HDAC4 (0.57) PTGS2HDAC4HDAC10HDAC6HDAC5
SCHEMBL10002025 0.82 HDAC4 (0.62) PTGS2HDAC4HDAC10HDAC6HDAC5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110045100-A1 Antimalarial Quinolines and Methods of Use Thereof GEORGETOWN UNIVERSITY (US) 2011-02-24 US disclosed
WO-2009148659-A2 ANTIMALARIAL QUINOLINES AND METHODS OF USE THEREOF GEORGETOWN UNIVERSITY (US) 2009-12-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110045100-A1 Antimalarial Quinolines and Methods of Use Thereof NQO2, QTRT1, QTRT2 PTGS2 1189/4885HDAC4 3044/4885HDAC10 2714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.